 "Dutch firm Corbion buys lactic acid business of Malladi Specialties")
Corbion Purac, the Netherlands-based specialty chemicals firm, has acquired the lactic acid business of the Chennai-based Malladi Specialties Limited - a Malladi Group Company, one of India's leading pharmaceutical companies - for an undisclosed amount. Two companies have signed an acquisition agreement today.
Malladi Specialties is a leading manufacturer of lactic acid and lactic acid based derivatives such as calcium lactate, sodium lactate and buffered lactic acid and supplies the pharmaceutical, home & personal care, chemical and food industries in India.
While the transaction includes the sales and delivery of lactic acid and lactic acid based derivatives in India, no production facilities will be acquired by Corbion. Production will remain with Malladi Drugs and Pharmaceuticals Limited (MDPL), also part of the Malladi Group, which will produce derivatives on behalf of Corbion Purac. Malladi Drugs is one of India's leading pharmaceuticals manufacturing company with a global presence. This transaction allows for a local production base through the partnership, while maintaining control on quality supplied to our customers. Corbion Purac has acquired the lactic acid business.
Frank Goovaerts, regional vice president, Corbion Purac Asia Pacific, commented, “For over 80 years Corbion Purac has been an established name and superior service provider in the food and pharmaceutical industry with lactic acid and its derivatives. MSL has a very strong customer base and distribution network in India. This acquisition will enable Corbion to grow its distribution network and customer service in India even further.”
Corbion is the global market leader in lactic acid, lactic acid derivatives, and lactides, and a leading company in functional blends containing enzymes, emulsifiers, minerals, and vitamins. The company also delivers biobased products made from renewable resources and applied in global markets like bakery, meat, culinary, pharma, home and personal care, and resins. Operating worldwide, Corbion generates annual sales of around Euro 770 million and employs a workforce numbering 1,893 in 20 countries.
Malladi Specialties is a leading manufacturer of lactic acid and lactic acid based derivatives such as calcium lactate, sodium lactate and buffered lactic acid and supplies the pharmaceutical, home & personal care, chemical and food industries in India.
While the transaction includes the sales and delivery of lactic acid and lactic acid based derivatives in India, no production facilities will be acquired by Corbion. Production will remain with Malladi Drugs and Pharmaceuticals Limited (MDPL), also part of the Malladi Group, which will produce derivatives on behalf of Corbion Purac. Malladi Drugs is one of India's leading pharmaceuticals manufacturing company with a global presence. This transaction allows for a local production base through the partnership, while maintaining control on quality supplied to our customers. Corbion Purac has acquired the lactic acid business.
Also Read
Corbion is the global market leader in lactic acid, lactic acid derivatives, and lactides, and a leading company in functional blends containing enzymes, emulsifiers, minerals, and vitamins. The company also delivers biobased products made from renewable resources and applied in global markets like bakery, meat, culinary, pharma, home and personal care, and resins. Operating worldwide, Corbion generates annual sales of around Euro 770 million and employs a workforce numbering 1,893 in 20 countries.